Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
170.90    -3.10 (-1.78%)
Bid:
171.10
Ask:
171.40
Spread: 0.30 (0.175%)
Market Cap: £755.86m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

FY26 pre-close statement

31 Mar 2026 07:00

RNS Number : 7165Y
Pets At Home Group Plc
31 March 2026
 

 

 

 

FOR IMMEDIATE RELEASE, 31 MARCH 2026

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

Pets at Home Group Plc: FY26 pre-close statement

Pets at Home Group plc, the UK's leading pet care business, is pleased to provide a pre-close update in respect of the 52-week period to 26 March 2026.

Group underlying profit before tax (PBT) for FY26 is expected to be c£92m, in line with previous guidance.

Our 'Retail Turnaround Plan' is progressing and is on track across our 4 priority areas, Product, Price, Execution and Cost. We have implemented our price investments and completed our £20m Group overhead savings, and while the benefits of many initiatives still lie ahead of us, we are encouraged by the progress made. In H2, our Retail business has seen volume growth, and we delivered positive LFL sales growth, as guided, with Q4 improving sequentially over Q3. Retail will deliver underlying PBT of c£30m in FY26.

In line with our guidance, Vet Group will deliver PBT of c£83m, a further year of strong profit progress despite the expected slowdown in sales growth as our customer cohorts reach a typical lull in activity. Vet Group performance remains underpinned by growth in average transaction values alongside growth in Care Plan revenues and plans.

Non-underlying costs of c£7m have been incurred in the year, in line with previous guidance.

We expect to finish FY26 in a net debt position of c£20m, after having returned c£85m to shareholders via dividends and buybacks during the year.

Following extensive consultation with our investors, we are rebalancing the way we return cash to shareholders. We will not change the total amount we return to shareholders but we will rebase our dividend to a 50% payout ratio, with that cash 'saving' returned to shareholders via our buyback programme.

We welcome the Final Decision Report of the CMA's veterinary services market investigation. We continue to expect no adverse impact on the growth strategy or ambitions for our Vet Group from the outcome.

Looking ahead to FY27, at this stage, we have c80% of our energy and FX requirements hedged and are comfortable with current analyst consensus expectations for Group underlying PBT1.

Our next scheduled update will be our FY26 preliminary results announcement on 27 May 2026.

 

1. Current analyst consensus for FY27 Group underlying PBT is £99m with a range of £90m - £108m.

 

Investor Relations Enquiries

Pets at Home Group Plc:

Andrew Porteous, Director of Investor Relations +44 (0) 7740 361 849

Aaron Wood, Head of Investor Relations +44 (0) 7702 083 154

Media Enquiries

Pets at Home Group Plc:

Natalie Cullington, Head of Communications +44 (0) 7974 594 701

Citigate Dewe Rogerson:

Jos Bieneman +44 (0) 7834 336 650

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products and care. Pet products are available online or from over 450 pet care centres, many of which also have vet practices and grooming salons. The Group also operates a leading small animal veterinary business, with over 450 veterinary general practices located both in our pet care centres and in standalone locations. For more information visit: http://petsathomeplc.com/

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser. Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result, you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

This announcement contains information that is inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (the Market Abuse Regulation ("MAR")). Upon the publication of this announcement, such information will no longer constitute inside information. Andrew Porteous, the Company's Director of Investor Relations, is the person responsible for making the notification for the purposes of Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTJMMMTMTAJTPF
Date   Source Headline
28th May 202111:00 amRNSDirector/PDMR Shareholding
27th May 20217:20 amRNSHolding(s) in Company
27th May 20217:00 amRNSFY21 Preliminary Results
21st May 202112:25 pmRNSHolding(s) in Company
28th Apr 202112:35 pmRNSChange in Director’s details
31st Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSChange in Director's details
17th Mar 20212:22 pmRNSHolding(s) in Company
15th Mar 20214:37 pmRNSHolding(s) in Company
11th Mar 20211:36 pmRNSHolding(s) in Company
5th Mar 20213:41 pmRNSHolding(s) in Company
26th Feb 20217:00 amRNSTrading Update
1st Feb 20213:14 pmRNSHolding(s) in Company
26th Jan 20213:39 pmRNSDirector/PDMR Shareholding
26th Jan 20213:37 pmRNSDirector/PDMR Shareholding
21st Jan 20217:00 amRNSTrading Statement
13th Jan 20212:04 pmRNSHolding(s) in Company
8th Jan 20217:00 amRNSTrading Update
31st Dec 202010:13 amRNSHolding(s) in Company
31st Dec 202010:04 amRNSDisposal of Specialist Group
29th Dec 20207:00 amRNSHolding(s) in Company
22nd Dec 20204:25 pmRNSDirectorate Change
18th Dec 20202:36 pmRNSDirector/PDMR Shareholding
8th Dec 20201:13 pmRNSDirectorate Change
4th Dec 20207:00 amRNSRepayment of business rates relief
1st Dec 20207:00 amRNSDisposal
30th Nov 20207:00 amRNSAcquisition
24th Nov 20207:00 amRNSFY21 Interim Results
23rd Nov 20207:00 amRNSHolding(s) in Company
18th Nov 20205:34 pmRNSHolding(s) in Company
4th Nov 20204:10 pmRNSHolding(s) in Company
2nd Nov 20204:25 pmRNSHolding(s) in Company
16th Oct 20204:18 pmRNSHolding(s) in Company
14th Oct 20207:00 amRNSHolding(s) in Company
9th Oct 20205:13 pmRNSHolding(s) in Company
8th Oct 20205:09 pmRNSHolding(s) in Company
6th Oct 20205:15 pmRNSDirector/PDMR Shareholding
6th Oct 20205:15 pmRNSDirector/PDMR Shareholding
5th Oct 20203:22 pmRNSHolding(s) in Company
2nd Oct 20204:24 pmRNSDirector/PDMR Shareholding
2nd Oct 20204:24 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSChange to Director Details
1st Oct 20204:19 pmRNSHolding(s) in Company
1st Oct 20201:04 pmRNSHolding(s) in Company
1st Oct 20207:00 amRNSAppointment of Joint Corporate Broker
28th Sep 20204:18 pmRNSHolding(s) in Company
28th Sep 202011:21 amRNSHolding(s) in Company
25th Sep 20209:14 amRNSHolding(s) in Company
24th Sep 20207:00 amRNSTrading Update
22nd Sep 20207:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.